XVIVO Perfusion published prospectus regarding the public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
The prospectus[1] regarding XVIVO Perfusion AB’s (publ) (”XVIVO Perfusion”) recommended public offer to the holders of shares (“Shares”) and warrants of series 2015/2016 (“Warrants”) in Vivoline Medical AB (“Vivoline”) to transfer all of their Shares and Warrants to XVIVO Perfusion (the “Offer”) has been approved by the Swedish Financial Supervisory Authority (the “SFSA”) and is now available on inter alia XVIVO Perfusion’s website.The Offer is not made, and this press release may not, directly nor indirectly, be distributed in or to, Australia, Hong Kong, Japan, Canada, New Zeeland, South